Small Talk: Axis-Shield stands firm in the face of £230m Alere bid

 

Axis-Shield is not for turning. At least not yet. Last week, the medical diagnostics company, which makes machines to test for conditions such as diabetes, published details of why it had said no to an offer from its American rival Alere Inc.

The saga dates back to July, when Alere made an indicative approach pegged at 460p a share, valuing Axis, which has its headquarters in Dundee, at about £230m. The response was swift. Shortly after news of the offer emerged, Axis said the unsolicited and preliminary proposal fundamentally undervalued its business.

Unperturbed, Alere came back in early August, this time with a formal, all-cash offer of 460p per Axis share. Cue another response from the target, which reiterated its view that the money just wasn't good enough in light of the business and its prospects. Alere, however, went ahead and posted an offer document on 11 August, giving shareholders until this Thursday to send in their acceptances.

Axis, unsurprisingly, remains against the idea and, last week, it told everyone exactly why it was opposed to the bid, recommending that "shareholders do not accept the offer and should take no action". The company said 460p a share was not enough to pay for the benefits it was now seeing from its investment in its Afinion testing machine, or from the promise held by the global lipid/cholesterol market – estimated to be worth about $500m by 2013 – that it planned to enter with Afinion's European launch later this year.

Moreover, it said, there were numerous opportunities for growth in the diabetes market in Asia and other emerging markets, where it had placed more than 21,000 of its NycoCard diabetes testing systems. "Alere has identified Axis-Shield's strengths and growth potential but wants to buy your company cheaply," the company's chairman, Dr John Brown, said in a letter to shareholders.

If the stock price is any guide, then the market certainly appears to agree with him, with Axis's shares closing at 480.25p on Friday – more than the 460p Alere is offering. This isn't surprising given past speculation regarding the possibility of another offer emerging from a company such as Abbott, Roche or even Siemens. Similarly, analysts appear unconvinced, with Numis questioning comparisons with the likes of Consort Medical. Its analyst Charles Weston said: "Recent comments from Alere reported in the press ... justifying the valuation by comparing Axis-Shield to Consort Medical strain the bounds of credulity, in our view, given the widely differing performance, growth prospects and markets between the two companies."

The Axis-watchers at DnB NOR Markets are equally adamant that 460p is just not enough, particularly given the chance that another suitor may yet emerge. "If an industrial player like Abbott, Roche or Johnson & Johnson were to acquire Axis-Shield, Alere would face much tougher competition in the lipid [cholesterol] market," it said. "The risk of this scenario supports our view that Alere would be willing to raise its offer. This would also be in line with how Alere has acted in previous acquisitions."

So, in the event Alere does ultimately relent and raise its bid, what could shareholders expect? Well, if DnB NOR's base-case scenario is any guide, it may raise its bid by 10 to 20 per cent, while Investec reckons that "a fairer price would be between 530p and 570p".

Whatever happens, this is certainly a company to watch over the coming days and weeks.

MoneySwap hedges bets on Macau casino tie-up

Another week, another listing on the Alternative Investment Market (Aim). This time it is the Hong Kong-based MoneySwap, which is preparing for its admission this Wednesday. The online money-exchange platform, which allows businesses and individuals to use the Swift banking system to transfer funds across different regions, is raising just over £3m with the listing, which is expected to value the firm at about £20m.

The money swap, so to speak, takes place through Swift – an established network that allows banks to exchange messages with each other – and boasts low fees and no minimum quantity. Once the transfer is completed, funds can be withdrawn via a recipient's bank account, or loaded on to one of the pre-paid MoneySwap MasterCards that are issued by partner banks.

The firm company currently has its sights set on the small businesses active in imports and exports in the Asia-Pacific region. Alongside this, Money-Swap said it is also targeting the many millions of remittances made by migrant labourers throughout Asia, and also at the lucrative gaming sector.

For the latter, it is working with the operators of the Melco Crown and Genting casino in Macau – China's answer to Las Vegas. The idea is to adapt the MoneySwap platform to allow visitors to deposit funds and receive payouts "in their place of departure and currency of choice", rather than at the casino in Macau.

This year is also set to bring a product launch, with Money-Swap gearing up to unveil its QuickPayIT solution in the third quarter. This will allow individuals to pay merchants for goods and services without either one having to enter or receive banking information, according to the company.

"We are delighted to be bringing MoneySwap on to the London Stock Exchange's Aim market," said Richard Proksa, the chief executive of MoneySwap. "The LSE has an exceptional standing in the minds of Asia-Pacific businesses and we see great competitive local advantage in being able to demonstrate that our company, processes and management team have all met the stringent requirements set by the LSE."

Start your day with The Independent, sign up for daily news emails
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Software Development Manager

£40000 - £50000 per annum: Recruitment Genius: This is an exciting opportunity...

Ashdown Group: Product Manager - (Product Marketing, Financial Services)

£30000 - £35000 per annum + Benefits: Ashdown Group: Marketing Manager - Marke...

Recruitment Genius: Compliance Assistant

£13000 per annum: Recruitment Genius: This Pension Specialist was established ...

Ashdown Group: Market Research Executive

£23000 - £26000 per annum + Benefits: Ashdown Group: Market Research Executive...

Day In a Page

As in 1942, Germany must show restraint over Greece

As in 1942, Germany must show restraint over Greece

Mussolini tried to warn his ally of the danger of bringing the country to its knees. So should we, says Patrick Cockburn
Britain's widening poverty gap should be causing outrage at the start of the election campaign

The short stroll that should be our walk of shame

Courting the global elite has failed to benefit Britain, as the vast disparity in wealth on display in the capital shows
Homeless Veterans appeal: The rise of the working poor: when having a job cannot prevent poverty

Homeless Veterans appeal

The rise of the working poor: when having a job cannot prevent poverty
Prince Charles the saviour of the nation? A new book highlights concerns about how political he will be when he eventually becomes king

Prince Charles the saviour of the nation?

A new book highlights concerns about how political he will be when he eventually becomes king
How books can defeat Isis: Patrick Cockburn was able to update his agenda-setting 'The Rise of Islamic State' while under attack in Baghdad

How books can defeat Isis

Patrick Cockburn was able to update his agenda-setting 'The Rise of Islamic State' while under attack in Baghdad
Judith Hackitt: The myths of elf 'n' safety

Judith Hackitt: The myths of elf 'n' safety

She may be in charge of minimising our risks of injury, but the chair of the Health and Safety Executive still wants children to be able to hurt themselves
The open loathing between Barack Obama and Benjamin Netanyahu just got worse

The open loathing between Obama and Netanyahu just got worse

The Israeli PM's relationship with the Obama has always been chilly, but going over the President's head on Iran will do him no favours, says Rupert Cornwell
French chefs get 'le huff' as nation slips down global cuisine rankings

French chefs get 'le huff' as nation slips down global cuisine rankings

Fury at British best restaurants survey sees French magazine produce a rival list
Star choreographer Matthew Bourne gives young carers a chance to perform at Sadler's Wells

Young carers to make dance debut

What happened when superstar choreographer Matthew Bourne encouraged 27 teenage carers to think about themselves for once?
Design Council's 70th anniversary: Four of the most intriguing prototypes from Ones to Watch

Design Council's 70th anniversary

Four of the most intriguing prototypes from Ones to Watch
Dame Harriet Walter: The actress on learning what it is to age, plastic surgery, and her unease at being honoured by the establishment

Dame Harriet Walter interview

The actress on learning what it is to age, plastic surgery, and her unease at being honoured by the establishment
Art should not be a slave to the ideas driving it

Art should not be a slave to the ideas driving it

Critics of Tom Stoppard's new play seem to agree that cerebral can never trump character, says DJ Taylor
Bill Granger recipes: Our chef's winter salads will make you feel energised through February

Bill Granger's winter salads

Salads aren't just a bit on the side, says our chef - their crunch, colour and natural goodness are perfect for a midwinter pick-me-up
England vs Wales: Cool head George Ford ready to put out dragon fire

George Ford: Cool head ready to put out dragon fire

No 10’s calmness under pressure will be key for England in Cardiff
Michael Calvin: Time for Old Firm to put aside bigotry and forge new links

Michael Calvin's Last Word

Time for Old Firm to put aside bigotry and forge new links